• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中铁浓度的改变:揭示铁死亡的潜在诊断生物标志物。

Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.

机构信息

Department of Neurosciences, University of Turin, 10124 Turin, Italy.

Neuroscience Research Center, University "Magna Graecia" of Catanzaro, 88100 Catanzaro, Italy.

出版信息

Int J Mol Sci. 2021 Apr 25;22(9):4479. doi: 10.3390/ijms22094479.

DOI:10.3390/ijms22094479
PMID:33923052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8123284/
Abstract

Proper functioning of all organs, including the brain, requires iron. It is present in different forms in biological fluids, and alterations in its distribution can induce oxidative stress and neurodegeneration. However, the clinical parameters normally used for monitoring iron concentration in biological fluids (i.e., serum and cerebrospinal fluid) can hardly detect the quantity of circulating iron, while indirect measurements, e.g., magnetic resonance imaging, require further validation. This review summarizes the mechanisms involved in brain iron metabolism, homeostasis, and iron imbalance caused by alterations detectable by standard and non-standard indicators of iron status. These indicators for iron transport, storage, and metabolism can help to understand which biomarkers can better detect iron imbalances responsible for neurodegenerative diseases.

摘要

所有器官(包括大脑)的正常运作都需要铁。它以不同的形式存在于生物体液中,其分布的改变会导致氧化应激和神经退行性变。然而,临床上通常用于监测生物体液(即血清和脑脊液)中铁浓度的参数很难检测到循环铁的量,而间接测量(如磁共振成像)则需要进一步验证。本文综述了脑铁代谢、铁平衡以及由标准和非标准铁状态指标可检测到的铁失衡的机制。这些铁转运、储存和代谢的指标有助于了解哪些生物标志物能更好地检测出导致神经退行性疾病的铁失衡。

相似文献

1
Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.阿尔茨海默病中铁浓度的改变:揭示铁死亡的潜在诊断生物标志物。
Int J Mol Sci. 2021 Apr 25;22(9):4479. doi: 10.3390/ijms22094479.
2
Ferroptosis as a mechanism of neurodegeneration in Alzheimer's disease.铁死亡在阿尔茨海默病神经退行性变中的作用机制。
J Neurochem. 2021 Dec;159(5):804-825. doi: 10.1111/jnc.15519. Epub 2021 Oct 9.
3
Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.缺乏H-铁蛋白的小鼠大脑铁浓度正常,但具有缺铁的蛋白质谱且氧化应激证据增加。
J Neurosci Res. 2003 Jan 1;71(1):46-63. doi: 10.1002/jnr.10463.
4
Brain and liver iron accumulation in aceruloplasminemia.无铜蓝蛋白血症患者脑和肝脏的铁蓄积
Neurology. 2013 Dec 10;81(24):2145-6. doi: 10.1212/01.wnl.0000437304.30227.bd.
5
Evidence for communication of peripheral iron status to cerebrospinal fluid: clinical implications for therapeutic strategy.外周铁状态与脑脊液之间通讯的证据:治疗策略的临床意义。
Fluids Barriers CNS. 2020 Apr 16;17(1):28. doi: 10.1186/s12987-020-00190-8.
6
Aceruloplasminemia.无铜蓝蛋白血症
Neuropathology. 2015 Feb;35(1):83-90. doi: 10.1111/neup.12149. Epub 2014 Aug 28.
7
MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.磁共振成像在脑型肝豆状核变性铁定量评估中的应用:一项尸检验证研究。
Neuroimage. 2021 Dec 15;245:118752. doi: 10.1016/j.neuroimage.2021.118752. Epub 2021 Nov 22.
8
[Ceruloplasmin (Cp) and iron in connection with Parkinson's disease (PD) and Alzheimer's disease (AD)].[铜蓝蛋白(Cp)与铁和帕金森病(PD)及阿尔茨海默病(AD)的关系]
Laeknabladid. 2012 Oct;98(10):531-7. doi: 10.17992/lbl.2012.10.457.
9
Iron and neurodegenerative disorders.铁与神经退行性疾病
Brain Res Bull. 2001 May 15;55(2):155-64. doi: 10.1016/s0361-9230(01)00510-x.
10
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.神经退行性疾病中涉及的铁死亡机制。
Int J Mol Sci. 2020 Nov 20;21(22):8765. doi: 10.3390/ijms21228765.

引用本文的文献

1
Iron Overload, Microbleeding and the Role of Bilirubin in Alzheimer's Disease Brain: Revisiting the Vascular Hypothesis.铁过载、微出血与胆红素在阿尔茨海默病大脑中的作用:重新审视血管假说
Int J Mol Sci. 2025 Mar 27;26(7):3060. doi: 10.3390/ijms26073060.
2
The Neural Palette of Heme: Altered Heme Homeostasis Underlies Defective Neurotransmission, Increased Oxidative Stress, and Disease Pathogenesis.血红素的神经调色板:血红素稳态改变是神经传递缺陷、氧化应激增加和疾病发病机制的基础。
Antioxidants (Basel). 2024 Nov 22;13(12):1441. doi: 10.3390/antiox13121441.
3
Alterations in zinc, copper, and iron levels in the retina and brain of Alzheimer's disease patients and the APP/PS1 mouse model.

本文引用的文献

1
Serum or plasma ferritin concentration as an index of iron deficiency and overload.血清或血浆铁蛋白浓度作为铁缺乏和铁过载的指标。
Cochrane Database Syst Rev. 2021 May 24;5(5):CD011817. doi: 10.1002/14651858.CD011817.pub2.
2
Machine Learning Profiling of Alzheimer's Disease Patients Based on Current Cerebrospinal Fluid Markers and Iron Content in Biofluids.基于当前脑脊液标志物和生物流体中铁含量的阿尔茨海默病患者的机器学习分析
Front Aging Neurosci. 2021 Feb 22;13:607858. doi: 10.3389/fnagi.2021.607858. eCollection 2021.
3
Ferroptosis Mechanisms Involved in Neurodegenerative Diseases.
阿尔茨海默病患者及APP/PS1小鼠模型视网膜和大脑中锌、铜和铁水平的变化。
Metallomics. 2024 Dec 2;16(12). doi: 10.1093/mtomcs/mfae053.
4
Iron accumulation/overload and Alzheimer's disease risk factors in the precuneus region: A comprehensive narrative review.楔前叶区域的铁蓄积/过载与阿尔茨海默病风险因素:一项全面的叙述性综述。
Aging Med (Milton). 2024 Oct 22;7(5):649-667. doi: 10.1002/agm2.12363. eCollection 2024 Oct.
5
Nitric Oxide Signaling and Sensing in Age-Related Diseases.一氧化氮在衰老相关疾病中的信号传导与感知
Antioxidants (Basel). 2024 Oct 9;13(10):1213. doi: 10.3390/antiox13101213.
6
A multi-ethnic proteomic profiling analysis in Alzheimer's disease identifies the disparities in dysregulation of proteins and pathogenesis.多民族蛋白质组学分析在阿尔茨海默病中的应用,确定了蛋白质失调和发病机制的差异。
PeerJ. 2024 Jul 18;12:e17643. doi: 10.7717/peerj.17643. eCollection 2024.
7
Iron Overload in Brain: Transport Mismatches, Microbleeding Events, and How Nanochelating Therapies May Counteract Their Effects.脑铁过载:转运不匹配、微出血事件,以及纳米螯合疗法如何抵消其影响。
Int J Mol Sci. 2024 Feb 16;25(4):2337. doi: 10.3390/ijms25042337.
8
Developing Iron Nanochelating Agents: Preliminary Investigation of Effectiveness and Safety for Central Nervous System Applications.开发铁纳米螯合剂:中枢神经系统应用的有效性和安全性初步研究。
Int J Mol Sci. 2024 Jan 5;25(2):729. doi: 10.3390/ijms25020729.
9
Visualization of ferroptosis in brain diseases and ferroptosis-inducing nanomedicine for glioma.脑疾病中铁死亡的可视化及用于胶质瘤的铁死亡诱导纳米药物
Am J Nucl Med Mol Imaging. 2023 Oct 20;13(5):179-194. eCollection 2023.
10
Emerging roles and therapeutic potentials of ferroptosis: from the perspective of 11 human body organ systems.铁死亡:从 11 个人体器官系统角度看新兴作用和治疗潜力。
Mol Cell Biochem. 2023 Dec;478(12):2695-2719. doi: 10.1007/s11010-023-04694-3. Epub 2023 Mar 13.
神经退行性疾病中涉及的铁死亡机制。
Int J Mol Sci. 2020 Nov 20;21(22):8765. doi: 10.3390/ijms21228765.
4
Low levels of salivary lactoferrin may affect oral dysbiosis and contribute to Alzheimer's disease: A hypothesis.唾液乳铁蛋白水平低可能影响口腔微生物群失调并促使阿尔茨海默病发生:一种假说。
Med Hypotheses. 2021 Jan;146:110393. doi: 10.1016/j.mehy.2020.110393. Epub 2020 Nov 13.
5
A mathematical model for the evaluation of iron transport across the blood-cerebrospinal fluid barrier in neurodegenerative diseases.一种用于评估神经退行性疾病中铁穿过血脑脊髓液屏障转运的数学模型。
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:2270-2273. doi: 10.1109/EMBC44109.2020.9175988.
6
Spotlight on Ferroptosis: Iron-Dependent Cell Death in Alzheimer's Disease.聚焦铁死亡:阿尔茨海默病中的铁依赖性细胞死亡
Front Aging Neurosci. 2020 Jul 14;12:196. doi: 10.3389/fnagi.2020.00196. eCollection 2020.
7
Decreased salivary lactoferrin levels are specific to Alzheimer's disease.唾液乳铁蛋白水平降低是阿尔茨海默病特有的。
EBioMedicine. 2020 Jul;57:102834. doi: 10.1016/j.ebiom.2020.102834. Epub 2020 Jun 22.
8
Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer's disease pathology.血浆转铁蛋白和血红素结合蛋白与阿尔茨海默病病理中 Aβ 摄取和认知能力下降有关。
Alzheimers Res Ther. 2020 Jun 9;12(1):72. doi: 10.1186/s13195-020-00634-1.
9
Evidence for communication of peripheral iron status to cerebrospinal fluid: clinical implications for therapeutic strategy.外周铁状态与脑脊液之间通讯的证据:治疗策略的临床意义。
Fluids Barriers CNS. 2020 Apr 16;17(1):28. doi: 10.1186/s12987-020-00190-8.
10
Association of Plasma Transferrin With Cognitive Decline in Patients With Mild Cognitive Impairment and Alzheimer's Disease.血浆转铁蛋白与轻度认知障碍和阿尔茨海默病患者认知功能下降的关联。
Front Aging Neurosci. 2020 Mar 12;12:38. doi: 10.3389/fnagi.2020.00038. eCollection 2020.